Biogen Stock Forecast

Stock Price Forecast

The 24 analysts with 12-month price forecasts for Biogen stock have an average target of 220.5, with a low estimate of 135 and a high estimate of 342. The average target predicts an increase of 56.78% from the current stock price of 140.64.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$135	$220.5	$210	$342
Change	-4.01%	+56.78%	+49.32%	+143.17%

Analyst Ratings

The average analyst rating for Biogen stock from 27 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	7	8	7	6	6	7
Buy	10	8	8	7	6	6
Hold	6	8	10	13	14	14
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	23	24	25	26	26	27

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Christopher Raymond Piper Sandler	Piper Sandler	Hold Reiterates $138 → $135	Hold	Reiterates	$138 → $135	-4.01%	Feb 18, 2025
George Farmer Scotiabank	Scotiabank	Buy Maintains $244 → $224	Buy	Maintains	$244 → $224	+59.27%	Feb 13, 2025
Evan Seigerman BMO Capital	BMO Capital	Hold Maintains $156 → $139	Hold	Maintains	$156 → $139	-1.17%	Feb 13, 2025
Matthew Harrison Morgan Stanley	Morgan Stanley	Hold Maintains $192 → $157	Hold	Maintains	$192 → $157	+11.63%	Feb 13, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Strong Buy Maintains $281 → $245	Strong Buy	Maintains	$281 → $245	+74.20%	Feb 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

9.63B

from 9.68B

-0.51%

from 9.68B

Revenue Next Year

9.78B

from 9.63B

1.57%

from 9.63B

EPS This Year

16.25

from 11.18

45.39%

from 11.18

EPS Next Year

16.50

from 16.25

1.52%

from 16.25

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	13.44B	10.98B	10.17B	9.84B	9.68B	9.63B	9.78B	10.16B
Revenue Growth	-6.49%	-18.32%	-7.36%	-3.32%	-1.62%	-0.51%	1.57%	3.94%
EPS	24.80	10.40	20.87	7.97	11.18	16.25	16.50	17.69
EPS Growth	-21.07%	-58.06%	100.67%	-61.81%	40.28%	45.39%	1.52%	7.21%
Forward PE	-	-	-	-	-	8.65	8.52	7.95
No. Analysts	-	-	-	-	-	38	32	24

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	11.0B	11.4B	12.1B
Avg	9.6B	9.8B	10.2B
Low	8.4B	8.3B	9.0B

Revenue Growth

Revenue Growth	2025	2026	2027
High	13.7%	18.2%	24.2%
Avg	-0.5%	1.6%	3.9%
Low	-13.0%	-14.0%	-8.3%

EPS Forecast

EPS	2025	2026	2027
High	21.15	21.68	26.79
Avg	16.25	16.50	17.69
Low	11.78	12.78	14.26

EPS Growth

EPS Growth	2025	2026	2027
High	89.2%	33.4%	62.3%
Avg	45.4%	1.5%	7.2%
Low	5.4%	-21.4%	-13.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.